Aprea Therapeutics, Inc. (APRE)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.54
- As of
Kresmion compiles this page from APRE's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Aprea Therapeutics, Inc. (APRE): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-28.
See the full APRE dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for APRE on one page. Preview it with sample data, then open it live with a free account.
Preview the APRE dossierActive events for APRE
- mediumEarnings above estimates
Q2-2026: Beat consensus by 70.8%, EPS $-0.07 vs $-0.2397 estimate
- high13F: large increase
RENAISSANCE TECHNOLOGIES LLC added +322% to APRE (2026Q2)
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in APRE
- mediumEarnings above estimates
Q2-2025: Beat consensus by 30.3% - EPS $-0.53 vs $-0.7599 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 36.1% - EPS $-0.47 vs $-0.3453 estimate
FREE, NO ACCOUNT
Every event on APRE, as it fires
You are seeing 5 of 7 events recorded on APRE since 2026-07-21.
The five above landed across 4 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in APRE (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 03836J201 · 2026Q2 | $85K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 03836J201 · 2026Q2 | $47K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, APRE
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Follow APRE on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to APRE for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.